Abbvie Inc Drug Patent Portfolio

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status

Abbvie Inc's Family Patents

Given below is the complete list of Abbvie Inc's drugs and the patents protecting them.

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List

Should Investors Buy, Hold, or Sell ABBV Stock Following Its Nearly 23% Increase This Year? - The Globe and Mail

16 Sep, 2025

AbbVie Experiences 0.85% Decline Following $970 Million Decrease in Volume, Falling to 79th Position as a Leading Biopharma Company...

13 Sep, 2025

AbbVie Resolves Patent Conflict Over Rinvoq: Implications for Stock Performance - sharewise

13 Sep, 2025

Analysts Predict Multi-Billion Dollar Increase as AbbVie's Rinvoq Remains Without Generics Until 2037

12 Sep, 2025